Cargando…
Psychopharmacology of anxiety disorders
Exposure of the general population to a 1:4 lifetime risk of disabling anxiety has inspired generations of fundamental and clinical psychopharmacologists, from the era of the earliest benzodiazepines (BZ) to that of the selective serotonin reuptake inhibitors (SSRIs) and related compounds, eg, the s...
Autores principales: | Cassano, Giovanni B., Rossi, Nicolò Baldini, Pini, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181684/ https://www.ncbi.nlm.nih.gov/pubmed/22033867 |
Ejemplares similares
-
Sex differences in the psychopharmacological treatment of depression
por: Sramek, John J., et al.
Publicado: (2016) -
Pharmacotherapy for anxiety disorders in children and adolescents
por: Kodish, Ian, et al.
Publicado: (2011) -
Pharmacotherapy of anxiety disorders: a critical review
por: Koen, Nastassja, et al.
Publicado: (2011) -
Biological predictors of pharmacological therapy in anxiety disorders
por: Maron, Eduard, et al.
Publicado: (2015) -
Medication dependence and anxiety
por: von Moltke, Lisa L., et al.
Publicado: (2003)